393 related articles for article (PubMed ID: 33902623)
1. HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania.
Tubert J; Packel L; Hunter LA; Mfaume R; Njau P; Ramadhani AA; Liu JX; McCoy SI
AIDS Res Ther; 2021 Apr; 18(1):21. PubMed ID: 33902623
[TBL] [Abstract][Full Text] [Related]
2. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
Ngure K; Friedland BA; Szydlo DW; Roberts ST; Garcia M; Levy L; Akello CA; Reddy K; Palanee-Phillips T; Macdonald P; Siziba B; Soto-Torres L; Hosek S; Hillier SL; Nair G; Celum C; van der Straten A
PLoS One; 2023; 18(6):e0287525. PubMed ID: 37352296
[TBL] [Abstract][Full Text] [Related]
3. Reaching Adolescent Girls and Young Women With HIV Self-Testing and Contraception at Girl-Friendly Drug Shops: A Randomized Trial in Tanzania.
Hunter LA; Rao A; Napierala S; Kalinjila A; Mnyippembe A; Hassan K; Bertozzi SM; Mfaume R; Njau P; Liu JX; McCoy SI
J Adolesc Health; 2023 Jan; 72(1):64-72. PubMed ID: 36241492
[TBL] [Abstract][Full Text] [Related]
4. Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial.
Nair G; Celum C; Szydlo D; Brown ER; Akello CA; Nakalega R; Macdonald P; Milan G; Palanee-Phillips T; Reddy K; Tahuringana E; Muhlanga F; Nakabiito C; Bekker LG; Siziba B; Hillier SL; Baeten JM; Garcia M; Johnson S; McClure T; Levy L; Livant E; Jacobson C; Soto-Torres L; van der Straten A; Hosek S; Rooney JF; Steytler J; Bunge K; Parikh U; Hendrix C; Anderson P; Ngure K;
Lancet HIV; 2023 Dec; 10(12):e779-e789. PubMed ID: 37898146
[TBL] [Abstract][Full Text] [Related]
5. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
[TBL] [Abstract][Full Text] [Related]
6. Provider perspectives on PrEP for adolescent girls and young women in Tanzania: The role of provider biases and quality of care.
Pilgrim N; Jani N; Mathur S; Kahabuka C; Saria V; Makyao N; Apicella L; Pulerwitz J
PLoS One; 2018; 13(4):e0196280. PubMed ID: 29702659
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
[TBL] [Abstract][Full Text] [Related]
8. Adolescent Girls and Young Women's Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis.
Young AM; Mancuso N; Atujuna M; Tenza S; Chitukuta M; Kemigisha D; Ngure K; van der Straten A; Garcia M; Szydlo D; Soto-Torres L; Roberts ST
AIDS Behav; 2023 Dec; 27(12):3941-3951. PubMed ID: 37392268
[TBL] [Abstract][Full Text] [Related]
9. Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP?
Bhavaraju N; Shears K; Schwartz K; Mullick S; Jeckonia P; Murungu J; Persaud U; Vij A; Torjesen K
Curr HIV/AIDS Rep; 2021 Dec; 18(6):508-517. PubMed ID: 34910276
[TBL] [Abstract][Full Text] [Related]
10. How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis.
Roberts ST; Mancuso N; Williams K; Nabunya HK; Mposula H; Mugocha C; Mvinjelwa P; Garcia M; Szydlo DW; Soto-Torres L; Ngure K; Hosek S
J Int AIDS Soc; 2023 Nov; 26(11):e26189. PubMed ID: 37936551
[TBL] [Abstract][Full Text] [Related]
11. "They call me the 'Great Queen'": implementing the Malkia Klabu program to improve access to HIV self-testing and contraception for adolescent girls and young women in Tanzania.
Willard-Grace R; Abigail Cabrera F; Bykhovsky C; Douglas K; Hunter LA; Mnyippembe A; Mgunya KH; McCoy SI; Liu JX
Reprod Health; 2024 Feb; 21(1):21. PubMed ID: 38321482
[TBL] [Abstract][Full Text] [Related]
12. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
Rousseau E; Bekker LG; Julies RF; Celum C; Morton J; Johnson R; Baeten JM; O'Malley G
BMC Health Serv Res; 2021 Aug; 21(1):888. PubMed ID: 34454505
[TBL] [Abstract][Full Text] [Related]
13. Relationship dynamics and anticipated stigma: Key considerations for PrEP use among Tanzanian adolescent girls and young women and male partners.
Jani N; Mathur S; Kahabuka C; Makyao N; Pilgrim N
PLoS One; 2021; 16(2):e0246717. PubMed ID: 33596216
[TBL] [Abstract][Full Text] [Related]
14. Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.
Glaubius R; Ding Y; Penrose KJ; Hood G; Engquist E; Mellors JW; Parikh UM; Abbas UL
J Int AIDS Soc; 2019 May; 22(5):e25282. PubMed ID: 31074936
[TBL] [Abstract][Full Text] [Related]
15. Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
Tapsoba JD; Cover J; Obong'o C; Brady M; Cressey TR; Mori K; Okomo G; Kariithi E; Obanda R; Oluoch-Madiang D; Chen YQ; Drain P; Duerr A
PLoS Med; 2022 Sep; 19(9):e1004097. PubMed ID: 36095005
[TBL] [Abstract][Full Text] [Related]
16. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
[TBL] [Abstract][Full Text] [Related]
17. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.
Celum CL; Delany-Moretlwe S; Baeten JM; van der Straten A; Hosek S; Bukusi EA; McConnell M; Barnabas RV; Bekker LG
J Int AIDS Soc; 2019 Jul; 22 Suppl 4(Suppl Suppl 4):e25298. PubMed ID: 31328444
[TBL] [Abstract][Full Text] [Related]
18. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi.
Maseko B; Hill LM; Phanga T; Bhushan N; Vansia D; Kamtsendero L; Pettifor AE; Bekker LG; Hosseinipour MC; Rosenberg NE
PLoS One; 2020; 15(1):e0226062. PubMed ID: 31929547
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: "What Is This PrEP?"-Sources and Accuracy of HIV Pre-Exposure Prophylaxis (PrEP) Awareness Among Adolescent Girls and Young Women Attending Family Planning and Maternal Child Health Clinics in Western Kenya.
Dettinger JC; Pintye J; Dollah A; Awuor M; Abuna F; Lagat H; Kohler P; John-Stewart G; O'Malley G; Kinuthia J; Beima-Sofie K
J Acquir Immune Defic Syndr; 2021 Dec; 88(4):356-360. PubMed ID: 34379606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
